I Mab Ownership
| IMAB Stock | USD 1.07 0.03 2.73% |
Shares in Circulation | First Issued 2018-09-30 | Previous Quarter 80.9 M | Current Value 81.5 M | Avarage Shares Outstanding 79.9 M | Quarterly Volatility 25.3 M |
IMAB |
IMAB Stock Ownership Analysis
About 31.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. I Mab recorded a loss per share of 2.16. The entity had not issued any dividends in recent years. I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people. To learn more about I Mab call XiYong MBA at 240 745 6330 or check out https://ir.i-mabbiopharma.com.Besides selling stocks to institutional investors, I Mab also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different I Mab's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align I Mab's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
I Mab Quarterly Liabilities And Stockholders Equity |
|
About 11.0% of I Mab are currently held by insiders. Unlike I Mab's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against I Mab's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of I Mab's insider trades
IMAB Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as I Mab is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading I Mab backward and forwards among themselves. I Mab's institutional investor refers to the entity that pools money to purchase I Mab's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 63.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 58.4 K | Xtx Topco Ltd | 2024-09-30 | 43 K | Mariner Wealth Advisors Llc | 2024-09-30 | 31.5 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 30.6 K | Barclays Plc | 2024-09-30 | 30.4 K | Geode Capital Management, Llc | 2024-09-30 | 22 K | Susquehanna International Group, Llp | 2024-09-30 | 13.4 K | Millennium Management Llc | 2024-09-30 | 11.3 K | Hillhouse Capital Advisors, Ltd. | 2024-09-30 | 6.9 M | Caligan Partners Lp | 2024-09-30 | 3.5 M |
I Mab Outstanding Bonds
I Mab issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. I Mab uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IMAB bonds can be classified according to their maturity, which is the date when I Mab has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I Mab. If investors know IMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I Mab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share | Quarterly Revenue Growth (0.62) | Return On Assets | Return On Equity |
The market value of I Mab is measured differently than its book value, which is the value of IMAB that is recorded on the company's balance sheet. Investors also form their own opinion of I Mab's value that differs from its market value or its book value, called intrinsic value, which is I Mab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I Mab's market value can be influenced by many factors that don't directly affect I Mab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between I Mab's value and its price as these two are different measures arrived at by different means. Investors typically determine if I Mab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I Mab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.